Rhythm Pharmaceuticals RYTM Earnings Call Transcripts

NASDAQ RYTM
$113.95 +0.01 (+0.01%)
At close: Nov 10, 2026 · 4:00 PM EST
4 earnings calls on file for Rhythm Pharmaceuticals, from Q4 2025 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Rhythm Pharmaceuticals Q3 2026 Earnings Call

Nov 3, 2026 9,775 words · 43 min read
  • Dave ConnollyHead of Investor Relations
  • David MeekerChairman, Chief Executive Officer, and President
  • Jennifer LeeExecutive Vice President, Head of North America
  • Hunter SmithChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Rhythm Pharmaceuticals Earnings Call Transcripts

Calls4
LatestNov 3, 2026
SinceQ4 2025

Fiscal 2026

Fiscal 2025

All 4 Rhythm Pharmaceuticals transcripts Register to get access to Rhythm Pharmaceuticals’s earnings call transcripts.